These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 21470798

  • 1. Pulmonary function testing after stereotactic body radiotherapy to the lung.
    Bishawi M, Kim B, Moore WH, Bilfinger TV.
    Int J Radiat Oncol Biol Phys; 2012 Jan 01; 82(1):e107-10. PubMed ID: 21470798
    [Abstract] [Full Text] [Related]

  • 2. Baseline pulmonary function as a predictor for survival and decline in pulmonary function over time in patients undergoing stereotactic body radiotherapy for the treatment of stage I non-small-cell lung cancer.
    Henderson M, McGarry R, Yiannoutsos C, Fakiris A, Hoopes D, Williams M, Timmerman R.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):404-9. PubMed ID: 18394819
    [Abstract] [Full Text] [Related]

  • 3. Influence of the site of lobectomy and chronic obstructive pulmonary disease on pulmonary function: a follow-up analysis.
    Kushibe K, Kawaguchi T, Kimura M, Takahama M, Tojo T, Taniguchi S.
    Interact Cardiovasc Thorac Surg; 2009 May 01; 8(5):529-33. PubMed ID: 19201779
    [Abstract] [Full Text] [Related]

  • 4. Short-term effects of inhalative tiotropium/formoterol/budenoside versus tiotropium/formoterol in patients with newly diagnosed chronic obstructive pulmonary disease requiring surgery for lung cancer: a prospective randomized trial.
    Bölükbas S, Eberlein M, Eckhoff J, Schirren J.
    Eur J Cardiothorac Surg; 2011 Jun 01; 39(6):995-1000. PubMed ID: 20970351
    [Abstract] [Full Text] [Related]

  • 5. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M, Klement RJ, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Xiao Y, Grills IS.
    Int J Radiat Oncol Biol Phys; 2013 Mar 15; 85(4):1074-81. PubMed ID: 23154077
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
    Borst GR, De Jaeger K, Belderbos JS, Burgers SA, Lebesque JV.
    Int J Radiat Oncol Biol Phys; 2005 Jul 01; 62(3):639-44. PubMed ID: 15936539
    [Abstract] [Full Text] [Related]

  • 11. Withholding stereotactic radiotherapy in elderly patients with stage I non-small cell lung cancer and co-existing COPD is not justified: outcomes of a Markov model analysis.
    Louie AV, Rodrigues G, Hannouf M, Lagerwaard F, Palma D, Zaric GS, Haasbeek C, Senan S.
    Radiother Oncol; 2011 May 01; 99(2):161-5. PubMed ID: 21620503
    [Abstract] [Full Text] [Related]

  • 12. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer - a first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study.
    Baumann P, Nyman J, Hoyer M, Gagliardi G, Lax I, Wennberg B, Drugge N, Ekberg L, Friesland S, Johansson KA, Lund JS, Morhed E, Nilsson K, Levin N, Paludan M, Sederholm C, Traberg A, Wittgren L, Lewensohn R.
    Radiother Oncol; 2008 Sep 01; 88(3):359-67. PubMed ID: 18768228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Association of chronic obstructive pulmonary disease and tumor recurrence in patients with stage IA lung cancer after complete resection.
    Sekine Y, Yamada Y, Chiyo M, Iwata T, Nakajima T, Yasufuku K, Suzuki M, Fujisawa T.
    Ann Thorac Surg; 2007 Sep 01; 84(3):946-50. PubMed ID: 17720404
    [Abstract] [Full Text] [Related]

  • 16. Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.
    Baldi S, Ruffini E, Harari S, Roviaro GC, Nosotti M, Bellaviti N, Venuta F, Diso D, Rea F, Schiraldi C, Durigato A, Pavanello M, Carretta A, Zannini P.
    J Thorac Cardiovasc Surg; 2005 Dec 01; 130(6):1616-22. PubMed ID: 16308007
    [Abstract] [Full Text] [Related]

  • 17. Is pulmonary function damaged by neoadjuvant lung cancer therapy? A comprehensive serial time-trend analysis of pulmonary function after induction radiochemotherapy plus surgery.
    Margaritora S, Cesario A, Cusumano G, Cafarotti S, Corbo GM, Ferri L, Ceppi M, Meacci E, Valente S, D'Angelillo RM, Russo P, Porziella V, Bonassi S, Pasqua F, Sterzi S, Granone P.
    J Thorac Cardiovasc Surg; 2010 Jun 01; 139(6):1457-63. PubMed ID: 20363001
    [Abstract] [Full Text] [Related]

  • 18. Exercise capacity after lobectomy in patients with chronic obstructive pulmonary disease.
    Kushibe K, Kawaguchi T, Kimura M, Takahama M, Tojo T, Taniguchi S.
    Interact Cardiovasc Thorac Surg; 2008 May 01; 7(3):398-401. PubMed ID: 18270219
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.